Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03178383 · ClinicalTrials.gov registry record · NA
Integration of Cancer Health Activities Into African American Churches
A NA study, sponsored by University of Maryland, College Park.
- Completed
- Registry status
- NA
- Development phase
- 446
- Enrollment target
NCT03178383: Completed NA study, sponsored by University of Maryland, College Park.
NCT03178383 is a NA study that has completed, run by University of Maryland, College Park. The registered enrollment target is 446 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03178383, a NA study, has completed, sponsored by University of Maryland, College Park.
- COMPLETED
- Registry status
- NA
- Development phase
- 446 participants
- Enrollment target
Study Summary
The proposed project will compare two ways to apply a known-effective cancer educational strategy through African American churches: 1) a standard method vs. 2) a new method in which the churches integrate the strategy into their organizational structure and practice at multiple levels. It will be determined whether this "integrated approach" results in more effective and sustained cancer education and screening activities at both the church and individual levels over time. This project will make important contributions to research in evidence-based medicine and sustainability. In a climate of limited resources, identifying sustainable and effective ways to increase cancer awareness and screening in African American men and women is more important than ever.
Primary Outcome
Intervention impact on institutionalization at 12 and 24 months
Interventions
- BEHAVIORAL Project HEAL
- BEHAVIORAL Project HEAL 2.0
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 446 participants |
| Start Date | 2016-07-01 |
| Est. Completion | 2022-06-30 |
| Phase | NA |
What the finished NCT03178383 record still lists
NCT03178383 is an interventional study that assigns participants to a tested intervention. The registered 446 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower).
The record links to 0 conditions, and to 2 interventions - of which Project HEAL is the first listed.
NCT03178383 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03178383 about?
NCT03178383 is a clinical study titled "Integration of Cancer Health Activities Into African American Churches". The proposed project will compare two ways to apply a known-effective cancer educational strategy through African American churches: 1) a standard method vs. 2) a new method in which the churches integrate the strategy into their organizational structure and practice at multiple levels. It will be d...
What is the current status of trial NCT03178383?
This trial is currently completed. It is a NA study. The enrollment target is 446 participants. The study started on 2016-07-01. Estimated completion is 2022-06-30.
What interventions are being tested in trial NCT03178383?
The interventions under investigation include: Project HEAL (BEHAVIORAL), Project HEAL 2.0 (BEHAVIORAL).
Who is sponsoring clinical trial NCT03178383?
This trial is sponsored by University of Maryland, College Park, which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03178383's enrollment target sits among peer trials
446 233rd of 2000 higher than 1,768 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04065399 · 447 participants · Phase 1
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- NCT01280994 · 445 participants · Phase 2
Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
- NCT03504800 · 445 participants
OCT in Diagnosis of Irregular Corneas
- NCT04751435 · 445 participants · NA
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI